Details of a Researcher

写真a

Masashi Kanayama

Job title

Assistant Professor

Hokkaido University, Graduate School, Division of Medicine, Doctor's Course, 2011.03, Completed

Chikuma S, Yamanaka S, Nakagawa S, Ueda MT, Hayabuchi H, Tokifuji Y, Kanayama M, Okamura T, Arase H, Yoshimura A. TRIM28 Expression on Dendritic Cells Prevents Excessive T Cell Priming by Silencing Endogenous Retrovirus. Journal of immunology (Baltimore, Md. : 1950). 2021.02; ( PubMed, DOI )
Izumi Y, Kanayama M, Shen Z, Kai M, Kawamura S, Akiyama M, Yamamoto M, Nagao T, Okada K, Kawamata N, Toyota S, Ohteki T. An Antibody-Drug Conjugate That Selectively Targets Human Monocyte Progenitors for Anti-Cancer Therapy. Frontiers in immunology. 2021; 12 618081. ( PubMed, DOI )
Liang J, Zhang JJ, Huang HI, Kanayama M, Youssef N, Jin YJ, Reyes EY, Abram CL, Yang S, Lowell CA, Wang D, Shao L, Shinohara ML, Zhang JY, Hammer GE. The ubiquitin-modifying enzyme A20 terminates C-type lectin receptor signals and is a suppressor of host defense against systemic fungal infection. Infection and immunity. 2020.06; ( PubMed, DOI )
Kanayama M, Izumi Y, Yamauchi Y, Kuroda S, Shin T, Ishikawa S, Sato T, Kajita M, Ohteki T. CD86-based analysis enables observation of bona fide hematopoietic responses. Blood. 2020.05; ( PubMed, DOI )
泉湧太, 金山剛士, 秋山めぐみ, 甲斐正之, 沈鐘楚子, 川又紀彦, 樗木俊聡. Targeting monocyte lineage-restricted antigen as a novel therapeutic strategy for monocytic leukemia(和訳中) 日本病理学会会誌. 2020.03; 109 (1): 304. ( ichushi )

Masashi Kanayama. CD86-based analysis enables identification of hematopoietic progenitors under biological stresses which upregulate interferon. 8th Annual Meeting of the International Cytokine & Interferon Society 2020.11.02
Masashi Kanayama. Balancing population sizes of myeloid and lymphoid cells by osteopontin isoforms. The 46th Annual Meeting of the Japanease Society for Immunology 2017.12.12 Sendai, Japan